|
Canada-0-EMBLEMS Azienda Directories
|
Azienda News:
- Multiplexed Immunofluorescence Analysis and Quantification of . . .
On a retrospective series of frozen tissue of renal cell carcinomas (RCC), using a fluorescence multispectral imaging technology coupled with an image analysis software, it was found that co-expression of PD-1 and Tim-3 on tumor infiltrating CD8 + T cells is correlated with a poor prognosis in RCC
- TIM-3 teams up with PD-1 in cancer immunotherapy: mechanisms and . . .
This study systematically investigates the fundamental biology of TIM-3 and PD-1, as well as the detailed mechanisms through which TIM-3 and PD-1 PD-L1 axis contribute to cancer immune evasion
- Analysis of PD1, LAG3, TIGIT, and TIM3 expression in human . . . - Cell Press
Their co-expression is associated with ICI resistance, irrespective of programmed cell death ligand-1 (PD-L1) status We also identify a 25-gene signature indicative of CD8 + T cell exhaustion with high predictive accuracy for ICI response
- Co-expression of PD-1 with TIGIT or PD-1 with TIM-3 on tumor . . .
Our findings for TIGIT were validated in The Cancer Genome Atlas (TCGA) CRC dataset This study is the first to report on the association of co-expression of PD-1 with TIGIT and PD-1 with TIM-3 in CD8+ T cells and improved DFS in treatment-naïve CRC patients
- Tumor infiltrating PD-1⁺TIM-3⁺CD8⁺ T cells are PD-1⁺TCF-1–TIM-3⁺. . .
Results: Our study provided evidence that S1PR3 high expression is positively associated with resistance to programmed cell death protein-1 (PD-1)-based immunotherapy and increased T-cell
- Triple checkpoint blockade of PD-1, Tim-3, and Lag-3 enhances . . . - PNAS
Our results offer insights regarding which signaling pathways may need to be disrupted cell intrinsically to enhance engineered adoptive T cell efficacy against solid tumors
- PD-1+ and TIM-3+ T cells widely express common γ-chain cytokine . . .
The stimulation with common γ-chain cytokines up-regulates PD-1 and TIM-3 during the proliferation of initially PD-1 TIM-3-negative T cells but fails to expand initially PD-1 + and TIM-3 + T cell subsets in vitro
- Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and . . .
In HIV patients, TIM-3 and PD-1 mark distinct populations of exhausted cells, with cells positive for both PD-1 and TIM-3 comprising the smallest fraction (Jones et al , 2008) of CD8 + T cells
|
|